Skip to content
2000
Volume 21, Issue 3
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Background

Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology. Several studies have suggested that interleukin-18 (IL-18) is associated with SLE pathogenesis. The genotype distribution of IL-18 promoter polymorphisms differs among ethnic populations. The present study aimed to investigate the correlation between IL-18 polymorphisms at positions -137 and -607 in patients situated in Northeastern Iran.

Methods

This case-control study examined the prevalence of IL-18 -137C/G and -607C/A polymorphic variants among 95 SLE patients referred to the Department of Rheumatology, who were referred to the general clinics of Ghaem Hospital and Imam Reza Hospital in Mashhad, Iran, were included in the study. In addition, 100 healthy individuals were included in the control group. DNA from whole blood was extracted by the salting-out method using a commercial kit (Biogene, US). Allelic and genotypic frequencies of polymorphisms (-137G/C, -607C/A) in the IL-18 promoter gene were analyzed using a polymerase chain reaction (PCR)-based amplification refractory mutation system (ARMS) method.

Results

The results of this study demonstrated that the frequency of SLE patients with the homozygous C/C genotype of the IL-18 promoter gene at position -137 was significantly higher than that of the homozygous G/G genotype ( < 0.001) in normal controls. Furthermore, the polymorphism analysis performed illustrated a significant association between (-137G/C) and (-607C/A) polymorphisms in the IL-18 promoter gene and SLE ( < 0.005).

Conclusion

These results indicated that the 607A/A and 137C/C polymorphisms are more prevalent in SLE. Further research involving larger sample sizes from various populations is necessary to elucidate the role of these polymorphisms and the distribution of alleles in SLE patients.

Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971304493240801094652
2024-08-16
2025-09-01
Loading full text...

Full text loading...

References

  1. TanakaY. State-of-the-art treatment of systemic lupus erythematosus.Int. J. Rheum. Dis.202023446547110.1111/1756‑185X.1381732134201
    [Google Scholar]
  2. Navarro QuirozE. Chavez-EstradaV. Macias-OchoaK. Ayala-NavarroM.F. Flores-AguilarA.S. Morales-NavarreteF. de la Cruz LopezF. Gomez EscorciaL. MussoC.G. Aroca MartinezG. Gonzales TorresH. Diaz PerezA. Cadena BonfantiA. Sarmiento GutierrezJ. MezaJ. Diaz ArroyoE. Bello LemusY. AhmadM. Navarro QuirozR. Epigenetic mechanisms and posttranslational modifications in systemic lupus erythematosus.Int. J. Mol. Sci.20192022567910.3390/ijms2022567931766160
    [Google Scholar]
  3. LiuZ. SunT. SongL. XueX. LiuS. KuangH. TianL. XiaoZ. Interleukin polymorphisms and predisposition of systemic lupus erythematosus: A meta-analysis.Int. Arch. Allergy Immunol.2021182101008101610.1159/00050748234375975
    [Google Scholar]
  4. YanikM. GurelM.S. SimsekZ. KatiM. The psychological impact of cutaneous leishmaniasis.Clin. Exp. Dermatol.200429546446710.1111/j.1365‑2230.2004.01605.x15347324
    [Google Scholar]
  5. UmareV. PradhanV. NathS. RajadhyakshaA. GhoshK. NadkarniA.H. Impact of functional IL-18 polymorphisms on genetic predisposition and diverse clinical manifestations of the disease in Indian SLE patients.Lupus201928454555410.1177/096120331983467730857465
    [Google Scholar]
  6. AlsahebfosoulF. Jahanbani-ArdakaniH. EtemadifarM. AbtahiS.H. Interleukin 18 polymorphisms and its serum level in patients with multiple sclerosis.Ann. Indian Acad. Neurol.201922447447610.4103/aian.AIAN_515_1831736573
    [Google Scholar]
  7. AringerM. Inflammatory markers in systemic lupus erythematosus.J. Autoimmun.202011010237410.1016/j.jaut.2019.10237431812331
    [Google Scholar]
  8. SongG.G. ChoiS.J. JiJ.D. LeeY.H. Association between interleukin-18 polymorphisms and systemic lupus erythematosus: A meta- analysis.Mol. Biol. Rep.20134032581258710.1007/s11033‑012‑2344‑y23238919
    [Google Scholar]
  9. MohsenM.A. Abdel KarimS.A. AbbasT.M. AminM. Serum interleukin-18 levels in patients with systemic lupus erythematosus: Relation with disease activity and lupus nephritis.Egypt. Rheumatol.2013351455110.1016/j.ejr.2012.09.005
    [Google Scholar]
  10. LiangR. ZhengL. JiT. ZhengJ. LiuJ. YuanC. HuangQ. YangM. Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.Lupus202231218719310.1177/0961203321106985335042378
    [Google Scholar]
  11. ItalianiP. MancaM.L. AngelottiF. MelilloD. PratesiF. PuxedduI. BoraschiD. MiglioriniP. IL-1 family cytokines and soluble receptors in systemic lupus erythematosus.Arthritis Res. Ther.20182012710.1186/s13075‑018‑1525‑z29422069
    [Google Scholar]
  12. XiangM. FengY. WangY. WangJ. ZhangZ. LiangJ. XuJ. Correlation between circulating interleukin-18 level and systemic lupus erythematosus: A meta-analysis.Sci. Rep.2021111470710.1038/s41598‑021‑84170‑433633218
    [Google Scholar]
  13. LiL.L. DengX.F. LiJ.P. NingN. HouX.L. ChenJ.L. Association of IL-18 polymorphisms with rheumatoid arthritis: A meta-analysis.Genet. Mol. Res.201615111410.4238/gmr.1501738926909913
    [Google Scholar]
  14. Garcia-SilvaR. Hernandez-DoñoS. Román-AmparoJ.P. Trujillo-VizuetM.G. Mena-VelaB.A. Rizo-PintoA. TiradoJ.M.P. Cetina-DíazJ.H. Bulos-RodríguezP. GranadosJ. Sepúlveda-DelgadoJ. Mayan alleles of the HLA-DRB1 major histocompatibility complex might contribute to the genetic susceptibility to systemic lupus erythematosus in Mexican patients from Tapachula, Chiapas.Clin. Rheumatol.20214083095310310.1007/s10067‑021‑05636‑433575923
    [Google Scholar]
  15. LinE. VincentF.B. SahharJ. NgianG.S. Kandane-RathnayakeR. MendeR. MorandE.F. LangT. HarrisJ. Analysis of serum interleukin (IL)-1α, IL -1β and IL -18 in patients with systemic sclerosis.Clin. Transl. Immunology201984e104510.1002/cti2.104530997045
    [Google Scholar]
  16. LiuS. LiJ. LiY. LiuY. WangK. PanW. Association between the interferon-γ+ 874 T/A polymorphism and the risk and clinical manifestations of systemic lupus erythematosus: A preliminary study.Pharm. Genomics Pers. Med.2021141475148210.2147/PGPM.S32349134848994
    [Google Scholar]
  17. XuW.D. PanH.F. YeD.Q. Association of interleukin-18 and systemic lupus erythematosus.Rheumatol. Int.201333123055305710.1007/s00296‑012‑2623‑x23263551
    [Google Scholar]
  18. RezaieyazdiZ. AkbariRadM. SaadatiN. SalariM. OrangR. SedighiS. EsmailyH. AzarpazhoohM.R. FirooziA. AkbarpourE. Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus.ARYA Atheroscler.20211761635685451
    [Google Scholar]
  19. LanY. WeiY.S. TangX.S. QinJ. WuJ. QinJ.M. Association of interleukin-18 gene polymorphism with genetic susceptibility to systematic lupus erythematosus in Guangxi Zhuang population.Zhonghua Yi Xue Yi Chuan Xue Za Zhi200825443443718683145
    [Google Scholar]
  20. AL-AboudyMH. Association between Interleukin-18 (-607 C→ A) polymorphisms and risk of chronic kidney disease.Ann. Rom. Soc. Cell Biol.20211507915086
    [Google Scholar]
  21. WangC. WeiL. ChuW. YuH. YuX. LiC. Correlation of interleukin-18 gene polymorphism with the susceptibility of condyloma acuminatum in Chinese population.Braz. J. Infect. Dis.201923638839410.1016/j.bjid.2019.09.00131634439
    [Google Scholar]
  22. FaridA. HanyA. KhaledA. SafwatG. Cytokines and autoantibodies profile during systemic lupus erythematosus and psoriasis diseases in Egypt.J. King Saud Univ. Sci.202234410200710.1016/j.jksus.2022.102007
    [Google Scholar]
/content/journals/crr/10.2174/0115733971304493240801094652
Loading
/content/journals/crr/10.2174/0115733971304493240801094652
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test